Clinical Trial Update: First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy [Phase 1]

View source ↗

Summary

This clinical trial update describes a first-in-human Phase 1 study of an interferon-gamma PET imaging tracer to assess immunotherapy response in non-small cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Interferon-gamma PET imaging tracer (interferon-gamma)

Snippet

Sponsor: Nerissa T. Viola | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING